EC | HEALTHCARE

Maximizes Daiichi Sankyo‘s value proposition of in-line and pipeline Cardiovascular products through delivery of aligned medical-scientific Information and responses to all European stakeholders (DSE, affiliates, as well as license partners). The position serves as Daiichi Sankyo (HQ) prime contact throughout Europe, in a matrix organization, to external and internal stakeholders on medical and scientific information and communication related to Daiichi Sankyo’s products within Cardiovascular therapeutic area and ensures that all medical information activities are planned and conducted in an excellent manner in line with Daiichi-Sankyo's Medical information strategy. ...

The Cardiovascular and Speciality Solutions (CSS) Group consists of different businesses and serves a diverse base of customers in Electrophysiology (Biosense Webster), Neurovascular (Cerenovus), Breast Aesthetics (Mentor), and Ear, Nose and Throat (Acclarent). The CSS medical director will be the EMEA medical leader for CSS, primarily focused on Biosense Webster and Cerenovus, and a core member of the EMEA CSS Extended Leadership Team and global CSS Preclinical Clinical Medical Extended Leadership Team. ...

The Senior Medical Director, Global Medical Affairs, Neurology & Immunology is accountable for the development & execution of GMA’s Evobrutinib global strategic and tactical plans for the asset in the Therapeutic Area of Neurology & Immunology. Key Accountabilities: Leads the Global Medical Affairs Team (GMAT) and is accountable for development of key GMAT deliverables for the asset, including unmet medical need assessment, scientific communication platform, external expert mapping and collaboration plans, scientific publication & congress plan, advisory boards, data gap analysis and post-approval data generation plans; ...